CD8A and cancer: While effector CD8+ T cells activated by antigen-presenting cells have long been considered the primary immune target because of their unique cytotoxicity, several studies in recent years have identified cytotoxic CD4+ T cells with a cytotoxicity program that can directly kill cancer cells [27].